Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Berek

Showing results (21-30 of 95) with videos related to

Pageof 10
Sort By:
Multiple Sclerosis and Related Disorders|July 25, 2020
Transverse myelitis as a rare presentation of antiphospholipid-antibody-associated disordersKlaus Berek, Elena Fava, Anne Zinganell, et al.
Journal of Neurology|March 5, 2024
Sex impacts treatment decisions in multiple sclerosisHarald Hegen, Klaus Berek, Florian Deisenhammer, et al.
Experimental Physiology|August 25, 2025
Early acclimatization to high altitude: Acid-base and fluid balance dynamics during the first 2 days at 3100 mElisabeth Skalla, Benedikt Treml, Sasa Rajsic, et al.
The Journal of Headache and Pain|May 21, 2015
Prevalence, management and burden of episodic and chronic headaches--a cross-sectional multicentre study in eight Austrian headache centresKarin Zebenholzer, Colette Andree, Anita Lechner, et al.
Scientific Reports|December 3, 2021
Experiences in treatment of multiple sclerosis with natalizumab from a real-life cohort over 15 yearsMichael Auer, Anne Zinganell, Harald Hegen, et al.
European Journal of Neurology|February 14, 2023
Immunization status in patients with multiple sclerosis: A cross-sectional, monocenter study in AustriaKlaus Berek, Philipp Deisl, Maximilian Bichler, et al.
European Journal of Neurology|October 19, 2020
Cerebrospinal fluid protein in Guillain-Barré syndrome: Need for age-dependent interpretationHarald Hegen, Felix Ladstätter, Gabriel Bsteh, et al.
Multiple Sclerosis and Related Disorders|January 3, 2020
To treat or not to treat: Sequential individualized treatment evaluation in relapsing multiple sclerosisGabriel Bsteh, Harald Hegen, Carolin Dosser, et al.
Journal of Central Nervous System Disease|April 4, 2022
Recovery of Chronic Inflammatory Demyelinating Polyneuropathy on Treatment With Ocrelizumab in a Patient With Co-Existing Multiple SclerosisMichael Auer, Harald Hegen, Anna Hotter, et al.
Frontiers in Immunology|March 5, 2026
Kappa free light chain index in CSF diagnostics: the impact of different immunoglobulin isotypesMartin Schmidauer, Klaus Berek, Michael Auer, et al.
Pageof 10

Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
Multiple Sclerosis and Related Disorders|July 25, 2020
Transverse myelitis as a rare presentation of antiphospholipid-antibody-associated disordersKlaus Berek, Elena Fava, Anne Zinganell, et al.
Journal of Neurology|March 5, 2024
Sex impacts treatment decisions in multiple sclerosisHarald Hegen, Klaus Berek, Florian Deisenhammer, et al.
Experimental Physiology|August 25, 2025
Early acclimatization to high altitude: Acid-base and fluid balance dynamics during the first 2 days at 3100 mElisabeth Skalla, Benedikt Treml, Sasa Rajsic, et al.
The Journal of Headache and Pain|May 21, 2015
Prevalence, management and burden of episodic and chronic headaches--a cross-sectional multicentre study in eight Austrian headache centresKarin Zebenholzer, Colette Andree, Anita Lechner, et al.
Scientific Reports|December 3, 2021
Experiences in treatment of multiple sclerosis with natalizumab from a real-life cohort over 15 yearsMichael Auer, Anne Zinganell, Harald Hegen, et al.
European Journal of Neurology|February 14, 2023
Immunization status in patients with multiple sclerosis: A cross-sectional, monocenter study in AustriaKlaus Berek, Philipp Deisl, Maximilian Bichler, et al.
European Journal of Neurology|October 19, 2020
Cerebrospinal fluid protein in Guillain-Barré syndrome: Need for age-dependent interpretationHarald Hegen, Felix Ladstätter, Gabriel Bsteh, et al.
Multiple Sclerosis and Related Disorders|January 3, 2020
To treat or not to treat: Sequential individualized treatment evaluation in relapsing multiple sclerosisGabriel Bsteh, Harald Hegen, Carolin Dosser, et al.
Journal of Central Nervous System Disease|April 4, 2022
Recovery of Chronic Inflammatory Demyelinating Polyneuropathy on Treatment With Ocrelizumab in a Patient With Co-Existing Multiple SclerosisMichael Auer, Harald Hegen, Anna Hotter, et al.
Frontiers in Immunology|March 5, 2026
Kappa free light chain index in CSF diagnostics: the impact of different immunoglobulin isotypesMartin Schmidauer, Klaus Berek, Michael Auer, et al.
Pageof 10